Tiletamine Hydrochloride — Complete Research Overview

Tiletamine Hydrochloride is a dissociative anaesthetic compound belonging to the arylcyclohexylamine class — the same chemical class as ketamine and phencyclidine. It was first developed in the 1960s and is characterised by its potent dissociative and anaesthetic properties making it a significant subject of interest in dissociative anaesthetic research and pharmacological studies. Tiletamine Hydrochloride is supplied as a white crystalline powder with 99.9% purity verified by HPLC laboratory testing. CAS number 14176-50-2. Its unique pharmacological profile compared to other dissociative compounds in the same class has made it a valuable research tool for scientists studying dissociative anaesthetic mechanisms, NMDA receptor activity and related neurological research.

Tiletamine was first synthesised in the 1960s during a period of significant research activity into dissociative anaesthetic compounds. It emerged from research programmes exploring alternatives to phencyclidine (PCP) which had been identified as having significant dissociative properties but problematic side effect profiles in research settings. Early pharmacological research established that tiletamine acts primarily as an NMDA receptor antagonist — blocking N-methyl-D-aspartate receptors in a similar mechanism to ketamine. This mechanism produces dissociative and anaesthetic effects and has made tiletamine a valuable research compound for scientists studying NMDA receptor function and the role of glutamate neurotransmission in anaesthetic states. Research through the 1970s and 1980s explored tiletamine extensively in combination studies. Scientists discovered that combining tiletamine with benzodiazepine compounds produced complementary pharmacological effects — a finding that significantly advanced understanding of how different classes of anaesthetic compounds interact at the receptor level. The unique pharmacokinetic profile of tiletamine compared to other NMDA antagonists has continued to attract research interest. Its longer duration of action relative to ketamine and its distinct receptor binding characteristics make it a useful comparative compound in studies exploring structure-activity relationships within the arylcyclohexylamine class. Contemporary research continues to explore tiletamine as a reference compound in neurological and anaesthetic studies contributing to the broader scientific understanding of dissociative anaesthetic mechanisms.

Tiletamine Hydrochloride should be stored in a cool dry place away from direct sunlight, heat and moisture. Recommended storage temperature is between 2°C and 8°C for optimal long term preservation of compound integrity. Keep container tightly sealed at all times when not in use. Store away from strong oxidising agents and incompatible chemical compounds. Proper storage under recommended conditions maintains the 99.9% purity of the compound. Shelf life is approximately 2 years under correct storage conditions. Always handle with appropriate laboratory protective equipment in a suitable research environment.

Available to Order

In Stock